Fidelity International’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$123K Sell
6,401
-1,189
-16% -$23.4K ﹤0.01% 978
2025
Q4
$144K Sell
7,590
-2,198
-22% -$40.7K ﹤0.01% 932
2025
Q3
$182K Sell
9,788
-695
-7% -$13K ﹤0.01% 885
2025
Q2
$193K Buy
10,483
+1,322
+14% +$23.5K ﹤0.01% 864
2025
Q1
$160K Buy
9,161
+2,649
+41% +$44.7K ﹤0.01% 842
2024
Q4
$113K Buy
6,512
+1,873
+40% +$34.2K ﹤0.01% 831
2024
Q3
$86.3K Sell
4,639
-5,790
-56% -$97.6K ﹤0.01% 850
2024
Q2
$161K Buy
+10,429
New +$149K ﹤0.01% 800

Other funds holding SBRA

Fidelity International's SBRA Position: Q1 2026 in Review

Fidelity International reduced its Sabra Healthcare REIT (SBRA) stake by 16% in Q1 2026, selling an estimated $23.4K and leaving 6,401 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #978.

Fidelity International first reported a position in SBRA in Q2 2024 and has held it in 8 quarters since. The position peaked at $193K in Q2 2025. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • Fidelity International held 6,401 shares of Sabra Healthcare REIT worth $123K as of Q1 2026.
  • Fidelity International sold 1,189 Sabra Healthcare REIT shares in Q1 2026, an estimated $23.4K.
  • Sabra Healthcare REIT made up ﹤0.01% of Fidelity International's portfolio in Q1 2026, its #978 holding.
  • Fidelity International first reported a position in Sabra Healthcare REIT in Q2 2024 and has held it in 8 quarters since.
  • Fidelity International's Sabra Healthcare REIT position peaked at $193K in Q2 2025.
  • 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Fidelity International's 13F filing for Q1 2026, filed 15 May 2026.